Stryker
Trade Stryker 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About SYK
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments.
SYK Key Statistics
Stock Snapshot
As of today, Stryker(SYK) shares are valued at $284.26. The company's market cap stands at 108.38B, with a P/E ratio of 29.28 and a dividend yield of 1.25%.
On 2026-10-13, Stryker(SYK) stock moved within a range of $284.26 to $284.50. With shares now at $284.26, the stock is trading 0.0% above its intraday low and -0.1% below the session's peak.
Trading activity shows a volume of 1.53K, compared to an average daily volume of 2.46M.
Over the past 52 weeks, Stryker(SYK) stock has traded between a high of $392.55 and a low of $267.00.
Over the past 52 weeks, Stryker(SYK) stock has traded between a high of $392.55 and a low of $267.00.
SYK News
Analyst Caitlin Roberts of Canaccord Genuity reiterated a Buy rating on Stryker, retaining the price target of $385.00. Caitlin Roberts has given his Buy rating...
BTIG analyst Ryan Zimmerman lowered the firm’s price target on Stryker (SYK) to $316 from $358 and keeps a Buy rating on the shares as part of a broader researc...
Stryker (SYK) and CMR Surgical announced a strategic equity investment of approximately $400M by Stryker with an exclusive option for Stryker to acquire the rem...
Analyst ratings
83%
of 30 ratingsMore SYK News
Stryker announced that long-serving CEO Kevin Lobo would step down at the end of 2026, with current President and COO Spencer Stiles becoming CEO and joining th...
Investing The Monopolistic Razor-and-Blade Engine I Can’t Stop Buying A 26% price drop on a stock with a near-monopoly business model and 85% recurring revenue...
Advertisement Leadership change at Stryker puts succession planning in focus Stryker (SYK) has moved into the spotlight after announcing that long-serving CEO...
Barclays initiated coverage of Stryker (SYK) with an Overweight rating and $375 price target The firm rolled out coverage of the medical suppliers and devices g...
Technology Stryker, Neogenomics Announce CEO Transitions; But One Stock Dives Licensing Stryker (SYK) and Neogenomics (NEO) stocks diverged Tuesday after the me...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.